Inventor
KATO MASATOMO
JP18 patents
⚠️ This page may combine multiple inventors who share the name “KATO MASATOMO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANTEN PHARMACEUTICAL CO LTD
7 patentsUS11419880B2Aug 23, 2022
Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
SANTEN PHARMACEUTICAL CO LTD2 citations71
US8017775B2Sep 13, 2011
1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD3 citations61
US8008498B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD1 citations61
US12290497B2May 6, 2025
Agent containing 4-phenylbutyrate, for preventing or treating presbyopia
SANTEN PHARMACEUTICAL CO LTD0 citations56
US8975256B2Mar 10, 2015
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008496B2Aug 30, 2011
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51
US8008497B2Aug 30, 2011
1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
SANTEN PHARMACEUTICAL CO LTD0 citations51
MATSUDA MAMORU
7 patentsUS8551991B2Oct 8, 2013
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
MATSUDA MAMORU3 citations61
US8193187B2Jun 5, 2012
1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity
MATSUDA MAMORU3 citations60
US8580784B2Nov 12, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8569493B2Oct 29, 2013
Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
MATSUDA MAMORU1 citations50
US8563551B2Oct 22, 2013
Method for preventing or treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8440660B2May 14, 2013
Method for treating a disease related to the glucocorticoid receptor
MATSUDA MAMORU0 citations50
US8420635B2Apr 16, 2013
Method for preventing or treating a glucocorticoid receptor-related disease
MATSUDA MAMORU0 citations50
KATO MASATOMO
2 patentsUS8664221B2Mar 4, 2014
Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
KATO MASATOMO2 citations56
US8426406B2Apr 23, 2013
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
KATO MASATOMO2 citations53